Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages
Autor: | Blanka Andersson, Daniel Eklund, Hanna Woksepp, Thomas B. Schön, Maria Lerm, Jim Werngren, Olle Stendahl, Johanna Raffetseder, Jonna Idh, Mikael Mansjö, Tommy Sundqvist |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
Bacterial Diseases
0301 basic medicine Antitubercular Agents lcsh:Medicine Infektionsmedicin Pathology and Laboratory Medicine Biochemistry Mice White Blood Cells chemistry.chemical_compound Animal Cells Medicine and Health Sciences lcsh:Science Cells Cultured Multidisciplinary biology Isoniazid food and beverages Neurochemistry Reactive Nitrogen Species Actinobacteria Chemistry Intracellular Pathogens Infectious Diseases Physical Sciences Anaerobic bacteria Cellular Types Neurochemicals Pathogens Research Article medicine.drug Infectious Medicine Tuberculosis Immune Cells Immunology 030106 microbiology Microbial Sensitivity Tests Anaerobic Bacteria Nitric Oxide Microbiology Mycobacterium tuberculosis 03 medical and health sciences Antibiotic resistance Peroxynitrous Acid Microbial Control Drug Resistance Bacterial medicine Animals Nitrites Reactive nitrogen species Pharmacology Microbial Viability Blood Cells Organisms Genetically Modified Bacteria Macrophages Intracellular parasite lcsh:R Organisms Chemical Compounds Biology and Life Sciences Cell Biology Macrophage Activation Tropical Diseases bacterial infections and mycoses medicine.disease biology.organism_classification chemistry Antibiotic Resistance Pretomanid lcsh:Q Antimicrobial Resistance Neuroscience |
Zdroj: | PLoS ONE, Vol 12, Iss 7, p e0181221 (2017) PLoS ONE |
ISSN: | 1932-6203 |
Popis: | Background Drugs such as isoniazid (INH) and pretomanid (PRT), used against Mycobacterium tuberculosis are active partly through generation of reactive nitrogen species (RNS). The aim of this study was to explore variability in intracellular susceptibility to nitric oxide (NO) in clinical strains of M. tuberculosis. Method Luciferase-expressing clinical M. tuberculosis strains with or without INH resistance were exposed to RNS donors (DETA/NO and SIN-1) in broth cultures and bacterial survival was analysed by luminometry. NO-dependent intracellular killing in a selection of strains was assessed in interferon gamma/lipopolysaccharide-activated murine macrophages using the NO inhibitor L-NMMA. Results When M. tuberculosis H37Rv was compared to six clinical isolates and CDC1551, three isolates with inhA mediated INH resistance showed significantly reduced NO-susceptibility in broth culture. All strains showed a variable but dose-dependent susceptibility to RNS donors. Two clinical isolates with increased susceptibility to NO exposure in broth compared to H37Rv were significantly inhibited by activated macrophages whereas there was no effect on growth inhibition when activated macrophages were infected by clinical strains with higher survival to NO exposure in broth. Furthermore, the most NO-tolerant clinical isolate showed increased resistance to PRT both in broth culture and the macrophage model compared to H37Rv in the absence of mutational resistance in genes associated to reduced susceptibility against PRT or NO. Conclusion In a limited number of clinical M. tuberculosis isolates we found a significant difference in susceptibility to NO between clinical isolates, both in broth cultures and in macrophages. Our results indicate that mycobacterial susceptibility to cellular host defence mechanisms such as NO need to be taken into consideration when designing new therapeutic strategies. Funding Agencies|Research Council of South East of Sweden; Swedish Heart and Lung Foundation; Swedish Research Council |
Databáze: | OpenAIRE |
Externí odkaz: |